NCT06065501

Brief Summary

This is a randomized controlled trial study conducted on frail patients with chronic kidney disease(CKD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 4, 2023

Completed
15 days until next milestone

Study Start

First participant enrolled

October 19, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
9 months until next milestone

Results Posted

Study results publicly available

June 26, 2025

Completed
Last Updated

June 26, 2025

Status Verified

June 1, 2025

Enrollment Period

12 months

First QC Date

September 26, 2023

Results QC Date

May 20, 2025

Last Update Submit

June 9, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Tilburg Frailty Indicator (TFI)

    Frailty was measured using the Tilburg Frailty Indicator (TFI), a 15-item self-reported questionnaire assessing physical, psychological, and social domains. Total score ranges from 0 to 15, with higher scores indicating greater frailty.

    Baseline, 3 months, and 6 months post-intervention

Secondary Outcomes (3)

  • Physical Activity Level Measured by IPAQ-Taiwan

    Baseline, 3 months, and 6 months post-intervention

  • Health-promoting Lifestyle Behaviors (HPLP-II, Taiwan Version)

    Baseline, 3 months, and 6 months post-intervention

  • Nutritional Status Measured by MNA-SF

    Baseline, 3 months, and 6 months post-intervention

Study Arms (2)

PACE intervention

EXPERIMENTAL

The intervention group (PACE intervention) utilizes mobile social network support, employing a LINE group to implement a personalized plan based on the TTM model for establishing a care program.

Behavioral: PACE intervention

Control group

ACTIVE COMPARATOR

The control group receives usual care, which involves standard CKD education and consultation.

Behavioral: Usual care

Interventions

"The PACE intervention involves using Line (technological devices) to establish a collaborative group with patients. The researchers will regularly provide reminders to chronic kidney disease patients regarding the importance of nutrition and exercise. They will also provide information on how to adhere to nutritional and exercise regimens, offering praise for consistent performance."

PACE intervention
Usual careBEHAVIORAL

Nurses provide routine education and consultation

Control group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with CKD stage 1 to 5
  • Participants with pre-frail and frail conditions.
  • Having access to a mobile phone and is capable of using mobile social network application (Line)

You may not qualify if:

  • Received renal replacement therapy
  • Participants achieved TTM stage 5

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng Kung University Hospital

Tainan, Taiwan

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Professor Miaofen Yen / Professor of Nursing department
Organization
National Cheng Kung University

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Nursing College of Medicine, National Cheng Kung University

Study Record Dates

First Submitted

September 26, 2023

First Posted

October 4, 2023

Study Start

October 19, 2023

Primary Completion

September 30, 2024

Study Completion

September 30, 2024

Last Updated

June 26, 2025

Results First Posted

June 26, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations